Supplementary Figure S4 from Negative Hyperselection of Patients with HER2&lt;sup&gt;+&lt;/sup&gt; and &lt;i&gt;RAS&lt;/i&gt; Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study